Management of sulphone-resistant lepromatous leprosy.
D002991:Clofazimine / Q000627:therapeutic use; D003622:Dapsone / Q000008:administration & dosage / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D006801:Humans; D007918:Leprosy / Q000188:drug therapy*; D009166:Mycobacterium leprae / Q000187:drug effects; D013792:Thalidomide / Q000627:therapeutic use
D013792:Thalidomide; D003622:Dapsone; D002991:Clofazimine